Fig. 2From: Amorphous SiO2 nanoparticles promote cardiac dysfunction via the opening of the mitochondrial permeability transition pore in rat heart and human cardiomyocytesExposure to nanoSiO2 to rat and human cardiac mitochondria results in mitochondrial dysfunction, observed by a reduced oxygen consumption rate and mitochondrial membrane potential. For rat cardiomyocyte mitochondria (a-d), at incremental nanoSiO2 concentrations: a Representative recordings of OCR. Addition of succinate and ADP are denoted by arrows. b Decrease of OCR evaluated in state 4 and state 3. c Representative recordings of ΔΨm. Addition of succinate and ADP are denoted by arrows. d Decrease of ΔΨm. For human cardiomyocyte mitochondria, at incremental nanoSiO2 concentrations: e Representative recordings of OCR. Addition of oligomycin, FCCP, rotenone and Antimycin A are denoted by dashed lines. f Basal and maximum OCR, and spare reserve. The exposure of mitochondria to nanoSiO2 was 5 min prior to measurements. Values represent mean ± SEMBack to article page